Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Adjuvant
Deletion
Attitudes of health personnel
Dialysis
Effectiveness
Covidom
Immunocompromised
Booster response
Attitude to health
Digital care
EMA
Determinants
Déterminants
Chemotherapy
Biomarkers
Conditional marketing authorization
1790GAHB F
ANTIRETROVIRAL THERAPY
Conjugate pneumococcal vaccine
Coadministration
Dendritic cells
Cystic fibrosis
Epidemiology
Assay
Delphi study
Digital health intervention
Covid 19
Immunogenicity
Vaccines
Vaccine hesitancy
Innate immunity
Alpha variant
Disinformation
Efficacy
COVID-19 vaccines
AIDS
Respiratory syncytial virus
Cancer
Antiviral
France
Elderly
Boys
Awareness
Attitude
AON
Clinical skills
Drug
Antiviral therapy
Adverse effects
Acute kidney injury
Sleep
Hesitancy
Co-morbidities
Coronavirus
Antiretroviral therapy
AstraZeneca vaccine
Cohort
Risk factors
COVID-19
Data sharing
Vaccine acceptance
EHealth literacy
CERVICOVAGINAL SECRETIONS
Adenoviral vector
Determinant
Clinical trials
Calcium phosphorus evaluation
SARS-CoV-2
B-lymphocytes
DMD
HPV vaccine
Influenza-like illness
Internet
Misinformation
Vaccine safety and efficacy
Influenza
HIV
Antiviral agents
C-type lectin receptor
Diabetes mellitus type 2
Vaccination
Vaccine effectiveness
Practices
Adults
Clinical practice
Covid-19
Dose escalation
Immunization
Vaccine
Chronic kidney disease
Catch-up
Clinical research
Care management
Cohort study
Incidence
Healthcare workers
COCONEL cohort surveys
Confidence
Cost of illness
Attitudes